Pharma: Regeneron has reached a drug pricing agreement with Trump to provide a new hearing-loss therapy at no cost.
Regeneron joins a growing list of major pharmaceutical companies making pricing concessions for both new and existing drugs as part of agreements with the Trump administration. This trend highlights the ongoing efforts to make medications more affordable. #PharmaNews #DrugPricing
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
